Live Demo:
This is a live DrugChatter demonstration using real AI-generated drug queries and analysis.
Want to see how your drug is represented by AI?
Contact DrugChatter
ozempic
Brand Visibility Tracking
How this brand shows up in AI chatbot answers — presence, position, sentiment, and how it stacks up against competitors.
–
Score / 100
Latest check
Weighted composite of presence, position, sentiment, and recommendation strength across tracked prompts.
Presence
–
Avg. position
–
Lower is betterSentiment
–
Recommendation mix — latest check
How the brand was framed across the latest tracked prompts.
Competitive landscape — latest check
Visibility vs. sentiment. Bubble size reflects rank position (bigger = higher-ranked).
Best known for — latest check
Different approved treatment products (same active ingredient, different indication and typical dosing)
Clinically equivalent to other semaglutide brands
Greater weight loss and A1c reductions in clinical studies.
Improve glycemic control
Weekly injection
Core Claims — latest check
Not exactly the same product
Same active ingredient: semaglutide
Ozempic is primarily approved for type 2 diabetes
Wegovy is approved specifically for chronic weight management
The pens are not interchangeable without clinician guidance
Differentiators — latest check
Different indications (diabetes vs weight management)
Different dosing schedules and higher doses for Wegovy
Not interchangeable pens
Differences in how they’re prescribed and monitored (treatment goals, target weight loss vs glucose control, insurance coverage)
Pen/device differences drive administration differences
Competitor comparison — latest check
| Brand | Visibility | Sentiment | Position | Recommended |
|---|
30-day composite trends
Score
Overall composite score, per day.
Visibility vs. sentiment
Two lenses on the same conversations — how much the brand shows up, and how it's spoken about.
Average rank position
Where the brand lands among all brands mentioned, in reading order. Lower is better.
Recent checks
| Date | Score | Visibility | Position | Sentiment |
|---|---|---|---|---|
| Jul 17, 2026 | 68 | 70 | 1 | 61 |
| Jul 18, 2026 | 62 | 63 | 1 | 61 |
| Jul 19, 2026 | 64 | 63 | 1 | 60 |
| Jul 20, 2026 | 56 | 59 | 1 | 57 |
| Jul 21, 2026 | 63 | 68 | 1 | 63 |
| Jul 22, 2026 | 72 | 73 | 1 | 66 |
| Jul 23, 2026 | 62 | 64 | 1 | 59 |
| Jul 24, 2026 | 72 | 76 | 1 | 66 |
| Jul 25, 2026 | 64 | 65 | 1 | 63 |
| Jul 26, 2026 | 67 | 70 | 1 | 66 |
| Jul 27, 2026 | 62 | 63 | 1 | 64 |
| Aug 1, 2026 | 60 | 66 | 1 | 60 |
| Aug 2, 2026 | 63 | 63 | 1 | 54 |
| Aug 3, 2026 | 55 | 67 | 1 | 52 |
| Aug 4, 2026 | 59 | 66 | 1 | 56 |
| Aug 5, 2026 | 59 | 68 | 1 | 55 |
| Aug 6, 2026 | 58 | 64 | 0 | 55 |
| Aug 7, 2026 | 64 | 70 | 1 | 54 |
| Aug 8, 2026 | 60 | 68 | 0 | 58 |
| Aug 9, 2026 | 54 | 63 | 0 | 58 |
| Aug 10, 2026 | 64 | 67 | 1 | 56 |
| Aug 11, 2026 | 62 | 66 | 0 | 54 |
| Aug 12, 2026 | 55 | 62 | 0 | 47 |
| Aug 14, 2026 | 60 | 66 | 1 | 58 |
| Aug 15, 2026 | 61 | 67 | 1 | 57 |